Results 221 to 230 of about 2,408,243 (341)

Treating thin endometrium by Ayurvedic Medications: A Case Study

, 2023
Harsha Gambhire-Bhadugale, Tekawade UV, Suhas Herlekar, Manasi Kulkarni   +3 more
openalex   +2 more sources

Medical commitments Medical commitments Medical commitments

Archives of Advances in Biosciences, 2012
openaire   +1 more source

Medical rehabilitation

Journal of Rehabilitation Medicine, 1969
openaire   +3 more sources

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Patients' experiences and practices of medication literacy in inflammatory bowel disease: a qualitative study. [PDF]

Front Pharmacol
Pan W, Tian W, Li S, Zhao Y, He Y, Liu Y, Feng X.   +6 more
europepmc   +1 more source

Analysis of Concordance of Medication-Taking Behaviour in Tuberculosis Patients in Medan, Indonesia

, 2018
Arlinda Sari Wahyuni, Noni Novisari Soeroso, Dian Dwi Wahyuni   +2 more
openalex   +2 more sources

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Knowledge, attitude, and practice toward medication use among pregnant women attending Mansoura university hospital antenatal care clinics: an analytic cross-sectional study. [PDF]

BMC Pregnancy Childbirth
Metwally T, Orma M, Elbostany N, Ali Y, Abu Bakr Elsaid NM, Aly H.   +5 more
europepmc   +1 more source

Physician-pharmacist agreement about off-label use of medications in private clinical settings in Baghdad, Iraq

, 2017
Saad Abdulrahman Hussain, Ashwaq Najemaldeen Abbas, Hasan A Alhadad, Ali Azeez Al‐Jumaili, Zainab Saad Abdulrahman   +4 more
openalex   +2 more sources

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source